283 results
Page 4 of 15
8-K
EX-3.1
2pkl60q tjg5
18 Mar 22
Entry into a Material Definitive Agreement
5:14pm
8-K
EX-99.1
kogm3nu4baij7ej9m77
10 Nov 21
Diffusion Pharmaceuticals Reports Third Quarter Financial Results
8:01am
S-8
EX-4.8
5aot7dq36xnrfjg9t sd
12 Aug 21
Registration of securities for employees
4:50pm
8-K
EX-1.1
e0w2uden5ibfmqfvf
18 Feb 21
Diffusion Pharmaceuticals Announces $10 Million Bought Deal Offering of Common Stock
4:52pm
8-K
EX-4.1
b2ekff s5abgq48
18 Feb 21
Diffusion Pharmaceuticals Announces $10 Million Bought Deal Offering of Common Stock
4:52pm
424B5
k09 tffqtb1e5ymhu
17 Feb 21
Prospectus supplement for primary offering
12:00am
424B5
xrjx42
11 Feb 21
Prospectus supplement for primary offering
5:28pm
8-K
EX-99.1
pnh7ukx9wd76
12 Nov 20
Diffusion Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Business Updates
4:57pm
8-K
EX-10.1
h8agcwakmt5k5bll054
20 Oct 20
Diffusion Pharmaceuticals Appoints Dr. Chris Galloway as Chief Medical Officer
5:30pm